Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Otonomy Inc (OTIC)

Otonomy Inc (OTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Otonomy Inc 4796 EXECUTIVE DRIVE SAN DIEGO CA 92121 USA

www.otonomy.com P: 619-323-2200

Description:

Otonomy, Inc. engages in developing and commercializing therapeutics to address unmet medical needs in the otology market. It develops therapeutics for treatment of inner and middle ear disorders. The Company's product candidates under development includes AuriPro to treat pediatric patients with middle ear effusion; and OTO-104 for the treatment of patients with M'ni're's disease. Otonomy, Inc. is headquartered in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 582
Enterprise Value, $K -60,828
Shares Outstanding, K 68,527
Annual Sales, $ 130 K
Annual Net Income, $ -51,180 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -12,048 K
60-Month Beta 1.54
% of Insider Shareholders 1.09%
% of Institutional Shareholders 41.23%
Float, K 67,780
% Float 98.91%
Short Volume Ratio 0.16

Growth:

1-Year Return -99.61%
3-Year Return -99.62%
5-Year Return -99.77%
5-Year Revenue Growth -80.88%
5-Year Earnings Growth 78.05%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 11/10/22
Next Earnings Date 05/08/23
Earnings Per Share ttm -0.37
EPS Growth vs. Prev Qtr 5.26%
EPS Growth vs. Prev Year 5.26%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

OTIC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -39,369.23%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.02
Book Value/Share 0.00
Interest Coverage -30.99
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar